Skip to content

Clinical trials

Coronavirus Infections trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronavirus Infections Country / region: Brazil Clear all

70 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
202048
202114
20225
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed39
Unknown status17
Terminated10
Recruiting3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Sao Paulo General Hospital5
BioNTech SE4
Hospital Israelita Albert Einstein4
D'Or Institute for Research and Education3
Butantan Institute2
Eli Lilly and Company2
Federal University of Paraíba2
Pfizer2
Sanofi2
Universidade Federal do Rio de Janeiro2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronavirus Infections70
COVID-1951
Severe Acute Respiratory Syndrome12
Pneumonia6
Pneumonia, Viral6
Respiratory Distress Syndrome6
Virus Diseases6
Respiratory Tract Infections5
Lung Diseases4
Critical Illness3

Trials

Showing 76 to 70 of 70. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.